Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: A pathogenetic role in interstitial monocytes recruitment

Journal of the American Society of Nephrology

Volumn 7, Issue 6, 1996, Pages 906-913

  Grandaliano, Giuseppe ^a   Gesualdo, Loreto ^a   Ranieri, Elena ^a   Monno, Raffaella ^a   Montinaro, Vincenzo ^a   Marra, Fabio ^b   Schena, Francesco P ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute interstitial nephritis; IgA nephropathy; Tubulointerstitial damage

Indexed keywords

IMMUNOGLOBULIN A; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CHRONIC GLOMERULONEPHRITIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; PRIORITY JOURNAL; PROGNOSIS; RECEPTOR UPREGULATION;

EID: 0030377417     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Van Goor H, Ding G, Kees-Folts D, Grond J, Schreiner GF, Diamond JR: Macrophages and renal disease. Lab Invest 1994;71:456-464.
2. Hooke DH, Gee DC, Atkins RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 1987;31:964-972.
3. Alexopoulos E, Seron D, Hartley RB, Cameron JS: The role of interstitial infiltrates in IgA nephropathy: A study with monoclonal antibodies. Nephrol Dial Transplant 1989;13:404-412.
4. Risdon RA, Sloper JC, DeWardener HE: Relationship between renal function and histological changes found in renal biopsy specimens from patients with persistent glomerular nephritis. Lancet 1968;1:363-366.
5. Schainuk LI, Striker GE, Cutler RE, Benditt EP: Structural-functional correlations in renal disease. Part II: The correlations. Hum Pathol 1970;1:631-640.
6. Nathan CF: Secretory products of macrophages. J Clin Invest 1987;79:319-326.
7. Stahl RA: Chemoattractants cytokines (chemokines) and immune renal injury. Nephrol Dial Transplant 1995;10: 307-309.
8. Rovin BH, Yoshimura T, Tan L: Cytokine-induced production of monocyte chemoattractant Protein-1 by cultured human mesangial cells. J Immunol 1992;148: 2148-2153.
9. Satriano JA, Hora K, Shan Z, Stanley ER, Mori T, Schlondorff D: Regulation of monocyte chemoattractant protein-1 and macrophage colony-stimulating factor-1 by IFN γ, tumor necrosis factor-α IgG aggregates, and cAMP in mouse mesangial cells. J Immunol 1993;150: 1971-1978.
10. Rollins BJ, Yoshimura T, Leonard EJ, Pober JS: Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol 1990;136:1229-1233.
11. Schmouder RL, Strieter RM, Kunkel SL: Interferon γ regulation of human cortical epithelial cell-derived monocyte chemotactic peptide-1. Kidney Int 1993;44: 43-49.
12. Valente AJ, Graves DT, Vialle-Valentin CE, Delgado R, Schwarz CJ: Purification of a monocyte chemotactic factor secreted by non human primate vascular cells in culture. Biochemistry 1988;27:4162-4167.
13. Colotta F, Borre A, Wang JM, et al.: Expression of a monocyte chemotactic cytokine by human mononuclear cells. J Immunol 1992;148:760-765.
14. Rollins BJ, Walz A, Baggiolini M: Recombinant human MCP-1/JE induces chemotaxis, calcium flux, and the respiratory burst in human monocytes. Blood 1991;78: 1112-1116.
15. Yu X, Dluz S, Graves DT, et al.: Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc Natl Acad Sci USA 1992;89:6953-6957.
16. Nelken NA, Coughlin SR, Gordon D, Wilcox JN: Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 1991;88:1121-1127.
17. Koch AE, Kunkel SL, Harlow LA, Johnson B, Evanoff HL, Haines GK: Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992;90:772-779.
18. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT: Expression of monocyte chemoattractant protein-1 in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 1992;89:5371-5375.
19. Safirstein R, Megyesi J, Saggi SJ, et al.: Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 1991;261:F1095-F1101.
20. Diamond JR, Kees-Folt D, Ding G, Frye JE, Restrepo NC: Macrophages, monocytes chemoattractant peptide-1 and TGF β in experimental hydronephrosis. Am J Physiol 1994;266:F926-F933.
21. Eddy AA, Warren J: Expression and function of monocyte chemoattractant protein-1 in puromycin amino-nucleoside nephrosis. J Am Soc Nephrol 1993;4:600.
22. Lee KSM, Rao VM, Franklin WA, et al.: IgA nephropathy: Morphologie predictors of progressive renal disease. Hum Pathol 1982;13:314-322.
23. Rollins BJ, Stier P, Ernst T, Wong GG: The human homolog of the JE gene encodes a monocyte secretory protein. Mol Cell Biol 1989;509:4687-4695.
24. Gesualdo L, Di Paolo S, Milani S, et al.: Expression of platelet-derived growth factor receptors in normal and diseased human kidney. J Clin Invest 1994;94:50-58.
25. Eddy AA: Interstitial macrophages as mediators of renal fibrosis. Exp Nephrol 1995;3:76-79.
26. Eddy AA: Experimental insights into the tubulo-interstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5:1273-1287.
27. Diamond JR, Pesek-Diamond I: Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: Role of macrophages. Am J Physiol 1991;260: F779-F786.
28. Diamond JR, Pesek I, Ruggieri S, Karnowsky MJ: Essential fatty acid deficiency during acute puromycin nephrosis ameliorates late renal injury. Am J Physiol 1989;257:F798-F807.
29. Saito T, Atkins RC: Contributions of mononuclear leukocytes to the progression of experimental focal glomerular sclerosis. Kidney Int 1990;37:1076-1083.
30. Eddy AA, Li Z, McCulloch L: Macrophages may mediate interstitial fibrosis via the release of transforming growth factor beta in passive Heymann nephritis [Abstract]. J Am Soc Nephrol 1991;2:573A.
31. Gomez-Chiani M, Ortiz A, Seron D, Gonzalez E, Egido J: The intercrine superfamily and renal diseases. Kidney Int 1993;43[Suppl 39]:S81-S85.
32. Leonard EJ, Yoshimura T: Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1993;11:97-101.
33. Jiang Y, Beller DI, Frendl G, Graves DT: Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-2428.
34. Tang WW, Feng L, Mathison JC, Wilson CB: Cytokine expression, upregulation of intercellular adhesion molecule-1, and leukocyte infiltration in experimental tubulo-interstitial nephritis. Lab Invest 1994;70:631-638.
35. Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al.: Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci USA 1991;88:5252-5256.
36. Ong ACM, Fine LG: Tubular-derived growth factors and cytokines in the pathogenesis of tubulo-interstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 1994;23:205-209.
37. Lan HY, Nikolic-Paterson DJ, Atkins RC: Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis. Lab Invest 1992;67: 743-751.
38. Abboud HE: Growth factors and the kidney. Kidney Int 1993;43:252-267.
39. Mukaida N, Zachariae CCO, Gusella GL, Matsushima K: Dexamethasone inhibits the induction of monocyte chemotactic activating factor production by IL-1 or tumor necrosis factor. J Immunol 1991;146:1212-1215.
40. Noris M, Bernasconi S, Casiraghi F, et al.: Monocyte chemoattractant-1 (MCP-1) in lupus nephritis [Abstract]. J Am Soc Nephrol 1995;6:846A.